Sale!

HSPD1 Gene SPG13 Genetic Test

4,400 د.إ

-21%

The HSPD1 Gene SPG13 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the HSPD1 gene, which are associated with spastic paraplegia 13 (SPG13), a rare genetic disorder. This condition is part of a group of hereditary spastic paraplegias that primarily affect the lower limbs, leading to progressive muscle weakness and stiffness (spasticity). The test plays a crucial role in the early detection and management of the disorder, enabling healthcare providers to tailor treatments and interventions more effectively.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the HSPD1 gene that may be indicative of SPG13.

The cost of the HSPD1 Gene SPG13 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families cannot be overstated. Early diagnosis can significantly impact the quality of life, enabling those affected to access supportive therapies and interventions sooner.

Patients considering this test are encouraged to consult with their healthcare provider to understand its implications fully and discuss any concerns they may have about the genetic testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HSPD1 Gene SPG13 Genetic Test

At DNA Labs UAE, we offer the HSPD1 Gene SPG13 Genetic Test to diagnose neurological disorders. This test is specifically designed to identify mutations in the HSPD1 gene that are associated with hereditary spastic paraplegia (SPG13).

Test Details

The HSPD1 gene encodes for the heat shock protein 60 (HSP60), which plays a crucial role in protein folding and quality control within the mitochondria. Mutations in this gene have been linked to SPG13, a subtype of hereditary spastic paraplegia.

Components and Price

The cost of the HSPD1 Gene SPG13 Genetic Test is 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

After the sample is collected, the report will be delivered within 3 to 4 weeks.

Method

The HSPD1 Gene SPG13 Genetic Test utilizes Next-Generation Sequencing (NGS) technology. NGS allows for the simultaneous analysis of multiple genes or even the entire exome, which includes all protein-coding regions of the genome.

Test Type

This test is specifically designed for the diagnosis of neurological disorders, with a focus on SPG13.

Doctor and Test Department

The HSPD1 Gene SPG13 Genetic Test is performed by a neurologist in our Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who will be undergoing the HSPD1 Gene SPG13 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by SPG13.

Importance of the Test

NGS genetic testing for SPG13 can confirm a diagnosis and provide information about the specific genetic variant causing the condition. This information is crucial for genetic counseling, family planning, and potentially guiding treatment options in the future.

Test Name HSPD1 Gene SPG13 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for HSPD1 Gene SPG13 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with HSPD1 Gene SPG13
Test Details

HSPD1 is a gene that encodes for the heat shock protein 60 (HSP60), which is involved in protein folding and quality control within the mitochondria. Mutations in the HSPD1 gene have been associated with a subtype of hereditary spastic paraplegia called SPG13.

NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire exome (all protein-coding regions of the genome). This type of testing can be used to identify genetic variations, such as mutations or variants, in the HSPD1 gene that may be responsible for SPG13.

NGS genetic testing for SPG13 can help confirm a diagnosis and provide information about the specific genetic variant causing the condition. This information can be important for genetic counseling, family planning, and potentially guiding treatment options in the future.